GLP-1 Receptor Agonism

GLP-1 Receptor Agonism
Leans yes

GLP-1 receptor agonism with liraglutide directly improves insulin sensitivity and lowers glucose levels in individuals with obesity and prediabetes within two weeks, independent of weight loss, through a mechanism requiring GLP-1 receptor activation, as demonstrated by reversal with exendin(9-39) and absence of effect with endogenous incretin enhancement via sitagliptin.

89
Supports
0
Challenges

Evidence shows liraglutide improves insulin sensitivity and lowers glucose in obesity and prediabetes within two weeks via direct GLP-1 receptor activation, ...

1 claim
0 studies
GLP-1 Receptor Agonism | Science Knowledge | Fit Body Science